%0 Journal Article %A Jacob Horsager %A Uwe Walter %A Tatyana D Fedorova %A Katrine B. Andersen %A Casper Skjærbæk %A Karoline Knudsen %A Niels Okkels %A Paul von Weitzel-Mudersbach %A Stig Eric Dyrskog %A Bo Bergholt %A Per Borghammer %T Vagus nerve cross-sectional area in patients with Parkinson’s Disease – an ultrasound case-control study %D 2021 %R 10.1101/2021.02.15.21251731 %J medRxiv %P 2021.02.15.21251731 %X Background Vagal parasympathetic neurons are prone to degeneration in Parkinson’s disease (PD). High-resolution ultrasound can precisely estimate the cross-sectional area (CSA) of peripheral nerves. Here, we tested the hypothesis that vagus CSA is reduced in PD.Methods We included 56 healthy controls (HCs) and 63 patients with PD. Using a high-end ultrasound system equipped with a high-frequency transducer, five images were obtained of each nerve. The hypoechoic neuronal tissue was delineated offline with dedicated software and the CSA extracted.Results In the initial PD vs. HC comparison, no statistically significant differences were observed in mean left vagus CSA (HC: 1.97mm2, PD: 1.89mm2, P=0.36) or in mean right vagus CSA (HC: 2.37mm2, PD: 2.23mm2, P=0.17). The right vagus CSA was significantly larger than the left vagus CSA in both groups (P<0.0001). Females were overrepresented in the HC group and presented with generally smaller vagus CSAs. Consequently, sex-adjusted CSA was significantly smaller for the right vagus nerve of the PD group (P=0.041), but not for the left.Conclusion A small but significant reduction in sex-adjusted right vagus CSA was observed in patients with PD. The left vagus CSA was not significantly reduced in patients with PD. Ultrasound may not be a suitable method to detecting vagal axonal loss in individual patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported by the Lundbeck Foundation [grant number: R190-2014-4183]. The funding source had no role in any part of the study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Science Ethical Committees of the Central Denmark Region.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available upon request to the corresponding author. %U https://www.medrxiv.org/content/medrxiv/early/2021/02/19/2021.02.15.21251731.full.pdf